Log In
Print
BCIQ
Print
Print this Print this
 

deferiprone (Ferriprox)

  Manage Alerts
Collapse Summary General Information
Company Apotex Inc.
DescriptionOral iron chelating agent
Molecular Target Fe ion
Mechanism of ActionChelating agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationThalassemia
Indication DetailsTreat iron overloading in transfusion-dependent patients with thalassemia and iron overloading in transfusion-dependent patients with anemia for whom other iron chelating agents are inappropriate; Treat patients with thalassemia and other blood disorders requiring transfusion
Regulatory Designation

U.S. - Accelerated Approval (Treat iron overloading in transfusion-dependent patients with thalassemia and iron overloading in transfusion-dependent patients with anemia for whom other iron chelating agents are inappropriate)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today